Company Vicore Pharma Holding AB

Equities

VICO

SE0007577895

Biotechnology & Medical Research

Analysts' Consensus

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - Nasdaq Stockholm Other stock markets 11:29:39 2024-04-26 am EDT			5-day change	1st Jan Change
17.3 ^SEK	+3.72%		+6.00%	+22.00%

Apr. 04	Vicore Pharma Holding AB Announces Maarten Kraan, as Board Member Declined Re-Election	CI
Mar. 19	Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis	CI

Vicore Pharma Holding AB is a Sweden-based drug-development company. The Company's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The Company is a wholly owned subsidiary of Mintage Scientific AB.

Number of employees: 24

Managers	Title	Age	Since
Ahmed Mousa CEO	Chief Executive Officer	40	23-09-08
Hans Jeppsson DFI	Director of Finance/CFO	-	16-12-31
Elin Rosendahl CTO	Chief Tech/Sci/R&D Officer	-	20-11-15
Nina Carlén ADM	Chief Administrative Officer	-	09-11-30
Bertil Lindmark CTO	Chief Tech/Sci/R&D Officer	68	Dec. 31
Johan Raud CTO	Chief Tech/Sci/R&D Officer	-	17-12-31
Mikael Nygård PRN	Corporate Officer/Principal	-	-
Åsa Magnusson PRN	Corporate Officer/Principal	-	-
Jessica Shull PRN	Corporate Officer/Principal	-	20-12-31
Johanna Gräns PRN	Corporate Officer/Principal	-	15-05-31

Members of the board	Title	Age	Since
Jacob Uno Stanley Gunterberg CHM	Chairman	57	17-12-31
Johannes G. C. P. Schikan BRD	Director/Board Member	66	17-12-31
Michael Buschle BRD	Director/Board Member	64	22-12-31
Heidi Hunter BRD	Director/Board Member	66	19-12-31
Margareta Elisabeth Björk BRD	Director/Board Member	63	22-12-31
Maarten Kraan BRD	Director/Board Member	63	17-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	111,722,979	96,099,394 ( 86.02 %)	0	86.02 %

Name	Equities	%	Valuation
HealthCap AB 16.49 %	18,427,774	16.49 %	25 M kr
Fjärde AP-fonden 9.810 %	10,960,399	9.810 %	15 M kr
HBM Partners AG (Investment Management) 9.734 %	10,874,727	9.734 %	15 M kr
Hans Bo Göran Wessman 3.590 %	4,010,340	3.590 %	6 M kr
Unionen 3.386 %	3,782,539	3.386 %	5 M kr
C Worldwide Asset Management Fondsmæglerselskab A/S (Sweden) 2.998 %	3,350,000	2.998 %	5 M kr
Tredje AP-fonden 2.745 %	3,066,425	2.745 %	4 M kr
Jesper Lyckeus 2.414 %	2,697,000	2.414 %	4 M kr
Swedbank Robur Fonder AB 2.155 %	2,407,163	2.155 %	3 M kr
The Invus Group LLC 1.994 %	2,227,200	1.994 %	3 M kr

Vicore Pharma Holding AB

Kornhamnstorg 53

111 27, Stockholm

+46 3 17 88 05 60

http://www.vicorepharma.com

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

17.3 SEK

Average target price

61.5 SEK

Spread / Average Target

+255.49%

Consensus

Estimates Revisions

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
VICORE PHARMA HOLDING AB	+22.00%	176M
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103B
REGENERON PHARMACEUTICALS, INC.	+0.56%	95.28B
ARGENX SE	+1.69%	22.15B
BIONTECH SE	-17.37%	21.02B
GENMAB A/S	-9.30%	18.15B
WUXI APPTEC CO., LTD.	-41.01%	16.73B
BEIGENE, LTD.	-14.85%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+3.21%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.54%	12.17B

Bio Therapeutic Drugs